Earnings History Data for Fulcrum Therapeutics, Inc. (FULC) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Fulcrum Therapeutics, Inc.

Fulcrum Therapeutics Inc. is a clinical-stage biopharmaceutical company. It is focused on genetically defined diseases with an initial focus on rare diseases. Fulcrum Therapeutics Inc. is based in Cambridge, United States.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
13-11-2024 PM FULC Fulcrum Therapeutics, Inc. 227.14 N/A -0.40 -0.39 Fulcrum Therapeutics GAAP EPS of -$0.35 beats by $0.05
[11/13/2024 7:21 AM]
3.57 -0.07 
(-1.95%)
3.86 0.22 
(6.04%)
2.87 - 13.70 719,245 790,000 31,107
31-07-2024 PM FULC Fulcrum Therapeutics, Inc. 523.96 0.87 -0.06 -0.38 Fulcrum Therapeutics GAAP EPS of $0.87 beats by $0.88, revenue of $80M beats by $38.89M
[7/31/2024 7:18 AM]
9.25 0.84 
(9.99%)
8.96 0.55 
(6.54%)
3.14 - 13.70 1,273,702 460,000 12,913
13-05-2024 PM FULC Fulcrum Therapeutics, Inc. 464.51 -0.43 -0.44 -0.41 Fulcrum Therapeutics GAAP EPS of -$0.43 in-line
[5/13/2024 7:22 AM]
7.40 -0.07 
(-0.94%)
8.35 0.88 
(11.78%)
2.65 - 13.70 1,710,608 290,000 180,247
27-02-2024 PM FULC Fulcrum Therapeutics, Inc. 593.50 -0.40 -0.44 -0.50 Fulcrum Therapeutics GAAP EPS of -$0.40 beats by $0.04, revenue of $0.87M beats by $0.48M
[2/27/2024 7:10 AM]
10.25 0.52 
(5.34%)
9.90 0.17 
(1.75%)
2.25 - 10.50 1,384,993 580,000 1,220
07-11-2023 PM FULC Fulcrum Therapeutics, Inc. 240.49 -0.39 -0.44 -0.50 Fulcrum Therapeutics GAAP EPS of -$0.39 beats by $0.04, revenue of $0.76M misses by $0.29M
[11/7/2023 7:16 AM]
4.30 0.71 
(19.78%)
3.66 0.07 
(1.99%)
2.25 - 15.00 1,150,012 410,000 1,317
03-08-2023 PM FULC Fulcrum Therapeutics, Inc. 229.13 -0.38 -0.44 -0.83 Fulcrum Therapeutics GAAP EPS of -$0.38 beats by $0.06, revenue of $0.9M misses by $0.06M
[8/3/2023 10:18 AM]
3.85 0.03 
(0.79%)
4.10 0.28 
(7.33%)
2.25 - 15.00 709,290 560,000 128
15-05-2023 PM 7:15 AM ET
(May 15)
FULC Fulcrum Therapeutics, Inc. 196.39 -0.41 -0.47 -0.64 Fulcrum Therapeutics GAAP EPS of -$0.41 beats by $0.05, revenue of $0.3M misses by $0.68M
[5/15/2023 7:12 AM]
3.63 0.36 
(10.93%)
3.42 0.15 
(4.59%)
2.25 - 15.00 829,670 770,000 3,086
09-03-2023 PM 7:15 AM ET
(Mar 9)
FULC Fulcrum Therapeutics, Inc. 792.42 -0.50 -0.49 -0.58 Fulcrum Therapeutics GAAP EPS of -$0.50 misses by $0.01, revenue of $0.7M misses by $1.19M
[3/9/2023 7:12 AM]
4.82 -1.44 
(-23.00%)
5.23 -1.03 
(-16.45%)
3.21 - 24.79 3,133,035 2,120,000 38,160
08-11-2022 PM 7:00 AM ET
(Nov 8)
FULC Fulcrum Therapeutics, Inc. 317.44 -0.50 -0.62 -0.57 Fulcrum Therapeutics GAAP EPS of -$0.51 beats by $0.11, revenue of $1.18M misses by $1.36M
[11/8/2022 7:20 AM]
6.50 0.89 
(15.86%)
0.0 0.0 
(0.00%)
3.21 - 24.79 463,919 340,000 0
11-08-2022 PM 7:00 AM ET
(Aug 11)
FULC Fulcrum Therapeutics, Inc. 229.16 -0.83 -0.66 -0.60 Fulcrum Therapeutics GAAP EPS of -$0.83 misses by $0.17, revenue of $1.9M misses by $1.06M
[8/11/2022 7:23 AM]
7.54 -0.22 
(-2.84%)
7.38 -0.38 
(-4.90%)
3.21 - 33.10 514,052 540,000 571
09-05-2022 PM 7:00 AM ET
(May 9)
FULC Fulcrum Therapeutics, Inc. 359.61 -0.64 -0.63 -0.54 Fulcrum Therapeutics GAAP EPS of -$0.64 misses by $0.02, revenue of $2.6M misses by $1.34M
[5/9/2022 7:05 AM]
7.64 -0.99 
(-11.47%)
8.22 -0.41 
(-4.75%)
6.85 - 33.10 1,123,082 720,000 200
03-03-2022 PM 7:00 AM ET
(Mar 3)
FULC Fulcrum Therapeutics, Inc. 446.04 -0.58 -0.65 -0.64 Fulcrum Therapeutics GAAP EPS of -$0.58 beats by $0.09, revenue of $5.06M beats by $1.54M
[3/3/2022 7:14 AM]
11.07 -0.03 
(-0.27%)
11.06 -0.04 
(-0.36%)
6.85 - 33.10 385,380 290,000 1,602,264
04-11-2021 PM 7:00 AM ET
(Nov 4)
FULC Fulcrum Therapeutics, Inc. 886.97 -0.57 -0.64 -0.70 Fulcrum Therapeutics beats on revenue
[11/4/2021 7:05 AM]
21.15 0.67 
(3.27%)
21.15 0.0 
(0.00%)
6.85 - 33.10 1,021,981 370,000 4,760
10-08-2021 PM 7:00 AM ET
(Aug 10)
FULC Fulcrum Therapeutics, Inc. 264.70 -0.60 -0.65 -0.66 Fulcrum Therapeutics beats on revenue
[8/10/2021 7:08 AM]
18.77 10.44 
(125.33%)
13.19 4.86 
(58.34%)
6.85 - 22.09 98,865,897 230,000 4,238,718
06-05-2021 PM 7:00 AM ET
(May 6)
FULC Fulcrum Therapeutics, Inc. 371.48 -0.54 -0.66 -0.81 Fulcrum Therapeutics beats on revenue
[5/6/2021 7:12 AM]
10.58 0.51 
(5.06%)
10.20 0.13 
(1.29%)
7.01 - 22.39 83,881 90,000 2,251
04-03-2021 PM 7:00 AM ET
(Mar 4)
FULC Fulcrum Therapeutics, Inc. 402.91 -0.64 -0.72 -0.71 Fulcrum Therapeutics EPS beats by $0.08, beats on revenue
[3/4/2021 7:11 AM]
12.52 -2.07 
(-14.19%)
14.59 0.0 
(0.00%)
7.01 - 22.39 197,677 88,395 519
10-11-2020 PM 7:00 AM ET
(Nov 10)
FULC Fulcrum Therapeutics, Inc. 320.65 -0.70 -0.66 -0.97 Fulcrum Therapeutics EPS misses by $0.03, beats on revenue
[11/10/2020 7:08 AM]
10.88 0.06 
(0.55%)
10.82 0.0 
(0.00%)
6.66 - 22.96 135,220 213,932 504
11-08-2020 PM 7:00 AM ET
(Aug 11)
FULC Fulcrum Therapeutics, Inc. 469.41 -0.66 -0.80 -9.21 Fulcrum Therapeutics EPS beats by $0.13
[8/11/2020 7:03 AM]
9.39 -7.73 
(-45.15%)
11.70 -5.42 
(-31.66%)
4.37 - 22.96 1,127,330 31,509 14,472
13-05-2020 PM 7:00 AM ET
(May 13)
FULC Fulcrum Therapeutics, Inc. 410.02 -0.81 -0.75 0.00 Fulcrum Therapeutics EPS misses by $0.06
[5/13/2020 7:04 AM]
16.48 1.57 
(10.53%)
0.0 0.0 
(0.00%)
4.37 - 22.96 349,158 76,281 0